华利集团（300979）：4Q25经营筑底静待拐点到来

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 63.22 [1][10]. Core Views - The company reported a revenue increase of 4.1% year-on-year to RMB 24.98 billion for 2025, while net profit decreased by 16.5% to RMB 3.21 billion. The revenue for Q3 and Q4 of 2025 is expected to decline by 0.3% and 3.0% respectively, with net profit dropping by 20.7% and 22.6% [6][10]. - The company plans to distribute a dividend of RMB 21 per 10 shares, resulting in an estimated total dividend payout ratio of 76% for the year [6]. - Short-term profit pressure is attributed to several new factories being in the ramp-up phase, production lines being adjusted among different customers, and exchange losses due to RMB appreciation. However, the company maintains a solid fundamental base and expects performance to improve after the ramp-up phase [6][10]. Financial Performance - For 2025, the company anticipates a total sales volume of 227 million pairs of sports shoes, reflecting a year-on-year increase of 1.59%, with an average selling price (ASP) of approximately RMB 110.0, up 2.2% year-on-year [7]. - The operating profit margin is projected to decrease by 4.0 percentage points to 16.7%, with operating profit expected to decline by 16% to RMB 4.17 billion [7]. - The company expects a moderate recovery in demand in 2026, benefiting from positive performance guidance from key clients such as Adidas and Asics, which are projected to see revenue growth of high single digits and double digits respectively [8]. Supply Chain and Production Capacity - The company’s new factory in Indonesia is expected to start generating profits by Q2 2026, with a total capacity projected to reach 50-60 million pairs per year in the next 3-5 years [9]. - The new factory in Vietnam for Asics is also expected to achieve breakeven by the end of 2026, contributing to profit growth as production stabilizes [9]. Earnings Forecast and Valuation - The net profit forecast for 2025-2027 has been adjusted downwards by 5.3%, 12.0%, and 13.0% to RMB 3.21 billion, RMB 3.56 billion, and RMB 4.12 billion respectively [10]. - The company is assigned a PE ratio of 20.7x for 2026, reflecting its stable industry leadership and orderly capacity expansion post-ramp-up [10].